Side Effects Skyrocket in France With Levothyroxine Reformulation

Merck is being pressured to make the previous formulation available, despite concerns and limited supplies.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply